• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Myriad Genetics

Myriad Genetics

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Research and Markets: U.S. and Global Molecular Diagnostics in Infectious Disease Testing Market Report (Updated Edition)

    Research and Markets: U.S. and Global Molecular Diagnostics in Infectious Disease Testing Market Report (Updated Edition)

  2. Research and Markets: US Nucleic Acid Testing/NAT Market 2015-2019: Sales and Market Shares of Major Suppliers

    Research and Markets: US Nucleic Acid Testing/NAT Market 2015-2019: Sales and Market Shares of Major Suppliers

  3. Research and Markets: 2015-2019 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets

    Research and Markets: 2015-2019 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets

  4. Research and Markets: World Infectious Disease Molecular Diagnostics Market 2015-2019

    Research and Markets: World Infectious Disease Molecular Diagnostics Market 2015-2019

  5. Our Outlook for Health-Care Stocks

    While we remain bullish on the sector, health-care growth depends on the economy.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.